Pharmacological characterisation of GSK3335103, an oral αvβ6 integrin small molecule RGD-mimetic inhibitor for the treatment of fibrotic disease - Concepedia

Concepedia

Publication | Closed Access

Pharmacological characterisation of GSK3335103, an oral αvβ6 integrin small molecule RGD-mimetic inhibitor for the treatment of fibrotic disease

10

Citations

23

References

2021

Year

Alex L. Wilkinson, Alison E. John, John W. Barrett, Elaine Gower, Valerie S. Morrison, Yim Man, Kwok‐Tao Pun, James A. Roper, Jeni Luckett, Lee A. Borthwick,

European Journal of Pharmacology

References

	Year	Citations

Page 1